Summary
The isolation of deoxyguanosine-resistant 10T 1/2 mouse cell lines following stepwise selection in the presence of increasing concentrations of drug led to the identification of a highly metastatic line, as measured by the ability to form secondary tumors in syngenic mice after intravenous injection. This metastatic deoxyguanosine-resistant mutant was determined to be deficient in hypoxanthine-guanine phosphoribosyltransferase activity, accounting for the resistance to deoxyguanosine. Lectin-binding studies determined that the metastatic potential of high- and low-metastatic revertant clones of this deoxyguanosine-resistant mutant was negatively correlated to soybean agglutinin binding, but not to concanavalin A or wheat germ agglutinin binding. Examination of labelled cell-surface glycoproteins led to the identification of two glycoproteins, gp80 and gp48, which were present on the low-metastatic wild-type cell line but absent from the highly metastatic drug-resistant cells. Our studies suggest that these cell-surface glycoprotein alterations play a role in determining the malignant properties of the cells, and indicate that metastatic variants with the properties described in this report would be useful biological tools for investigations into the roles played by specific cell-surface structures in mechanisms of tumor progression.
Similar content being viewed by others
Abbreviations
- HGPRT:
-
hypoxanthine-guanine phosphoribosyltransferase
- WGA:
-
wheat germ agglutinin
- SBA:
-
soybean agglutinin
References
Aldaheff JA (1989) Malignant cell glycoproteins and glycolipids. Crit Rev Oncol Hematol 9:37–107
Altevogt P, Fogel M, Cheingsong-Popov R, Dennis J, Robinson P, Schirrmacher V (1983) Different patterns of lectin binding and cell surface sialylation detected in high- and low-metastatic tumor lines. Cancer Res 43:5138–5144
Barnett SC, Eccles SA (1984) Studies of mammary carcinoma metastasis in a mouse model system: II. Lectin binding properties of cells in relation to the incidence and organ distribution of metastasis. Clin Exp Metastasis 2:297–310
Blin N, Stafford DW (1976) A general method for isolation of high molecular DNA from eukaryotes. Nucleic Acid Res 3:2303–2308
Blosmanis R, Wright JA, Goldenberg GJ (1987) Sensitivity to melphalan as a function of transport activity and proliferative rate in BALB/c 3T3 fibroblasts. Cancer Res 47:1273–1277
Buckley ND, Carlsen SA (1988) Involvement of Soybean agglutinin binding cells in the lymphatic metastasis of the R3230AC rat mammary adenocarcinoma. Cancer Res 48:1451–1455
Collard JG, Schijven JF, Bikker A, LaRiviere G, Bolscher JGM, Roos E (1986) Cell surface sialic acid and the invasive and metastatic potential of T cell hybridomas. Cancer Res 46:3521–3527
Dennis JW, Laferte S (1987) Tumor cell surface carbohydrate and the metastatic phenotype. Cancer Metastatic Rev 5:185–204
Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G, Greenberg AH (1987) Expression of H-ras correlates with the metastatic potential: Evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH3T3 cells. Mol Cell Biol 7:830–837
Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13
Gough NM (1988) Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem 173:93–95
Greenberg AH, Egan SE, Jarolim L, Gingras MC, Wright JA (1987) Natural killer cell regulation of implantation and early lung growth of H-ras-transformed 10T1/2 fibroblasts in mice. Cancer Res 47:4801–4805
Greenberg AH, Egan SE, Wright JA (1989) Oncogenes and metastatic progression. Invasion Metastases 9:360–378
Gudas LJ, Ullman B, Cohen A, Martin DW Jr (1978) Deoxyguanosine toxicity in a mouse T lymphoma: relationship to purine nucleoside phosphorylase-associated immune dysfunction. Cell 14:531
Hards RG, Wright JA (1981)N-carbamoyloxyurea-resistant Chinese hamster ovary cells with elevated levels of ribonucleotide reductase activity. J Cell Physiol 106:309–319
Kerbel RS, Dennis JW, Lagarde AE, Frost P (1982) Tumor progression and metastasis: an experimental approach using lectin resistant tumor variants. Cancer Metastasis Rev 1:99–140
Laferte S, Dennis JW (1988) Glycosylation-dependent Collagenbinding activities of two membrane glycoproteins in MDAY-D2 tumor cells. Cancer Res 48:4743–4748
Lang E, Schirrmacher V, Altevogt P (1988) Molecular identification of lectin binding sites differentiating related low and high metastatic murine lymphomas. Clin Exp Metastasis 6:61–72
Ledbetter JA, Seaman WE, Tsu TT, Herzenberg LA (1981) Lyt-2 and Lyt-3 antigens are on two different polypeptide subunits linked by disulfide bonds. J Exp Med 153:1503–1516
Liotta LA (1986) Tumor invasion and metastasis — role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 46:1–7
McClarty GA, Chan A, Engstrom Y, Wright JA, Thelander L (1987) Elevated expression of M1 and M2 components and drug-induced posttranscriptional modulation of ribonucleotide reductase in a hydroxyurea-resistant mouse cell line. Biochemistry 26:8004–8011
Nabi IR, Raz A (1987) Cell shape modulation alters glycosylation of metastatic melanoma cell surface antigen. Int J Cancer 40:396–402
Nanden D, Ball EH, Sanwal BD (1990) Two proteins of the endoplasmic reticulum bind denatured collagen. Biochem Cell Biol 68:1057–1061
Nicander B, Reichard P (1985) Relations between synthesis of deoxyribonucleotide and DNA replication in 3T6 fibroblasts. J Biol Chem 260:5376–5381
Parfett CLJ, Jamieson JC, Wright JA (1983) Changes in cell surface glycoproteins on non-differentiating L6 rat myoblasts selected for resistance to concanavalin A. Exp Cell Res 144:405–415
Penno MB, Passaniti A, Fridman R, Hart GW, Jordan C, Kumar S, Scott AF (1989)In vitro galactosylation of a 110-kDa glycoprotein by an endogenous cell surface galactosyltransferase correlates with the invasiveness of adrenal carcinoma cells. Proc Natl Acad Sci USA 86:6057–6061
Poste G (1982) Experimental systems for analysis of the malignant phenotype. Cancer Metastasis Rev 1:141–201
Sidi Y, Mitchell BS (1984) 2-Deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. J Clin Invest 74:1640
Spearman MA, Jamieson JC, Wright JA (1987) Studies on the effect of glycoprotein processing inhibitors on fusion of L6 myoblast cell lines. Exp Cell Res 168:116–126
Tanner JM, Anstee DJ (1976) A method for the direct demonstration of the lectin-binding components of the human erythrocyte membrane. Biochem J 153:265–270
Ullman B (1989) Adenosine, deoxyadenosine and deoxyguanosine. In: Gupta RS (ed) Drug resistance in mammalian cells: vol 1. Antimetabolic and cytotoxic analogs. CRC Press, Boca Raton, pp 69–88
Ullman BG, Martin DW Jr (1984) Specific cytotoxicity of arabinosylguanine toward cultured T lymphoblasts. J Clin Invest 74:951
Ullman BG, Gudas LJ, Clift SM, Martin DW Jr (1979) Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: genetic model for immunodeficiency disease. Proc Natl Acad Sci USA 76:1074
Wright JA (1989) Altered mammalian ribonucleoside diphosphate reductase from mutant cell lines. Int Encycl Pharmacol Ther 128:89–111
Wright JA, Alam TG, McClarty GA, Tagger AY, Thelander L (1987) Altered expression of ribonucleotide reductase and role of M2 gene amplification in hydroxyurea-resistant hamster, mouse, rat and human cell lines. Somatic Cell Mol Genet 13:155–165
Wright JA, Hards RG, Dick JE (1981) Studies of mammalian ribonucleotide reductase activity in intact permeabilized cells: a genetic approach. Adv Enzyme Regul 19:105–127
Wright JA, Egan SE, Greenberg AH (1990) Genetic regulation of metastatic progression. Anticancer Res 10:1247–1256
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Damen, J.E., Spearman, M.A., Greenberg, A.H. et al. Characterization of deoxyguanosine-resistant hypoxanthine-guanine phosphoribosyltransferase− metastatic variants altered in soybean-agglutinin-binding properties and cell-surface glycoproteins. J Cancer Res Clin Oncol 117, 305–312 (1991). https://doi.org/10.1007/BF01630712
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01630712